D. Boral Capital initiated coverage on shares of Nano-X Imaging (NASDAQ:NNOX - Free Report) in a research report released on Monday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $23.00 target price on the stock.
Separately, Cantor Fitzgerald lifted their price target on shares of Nano-X Imaging from $11.00 to $12.00 and gave the company an "overweight" rating in a research report on Friday, December 6th.
Check Out Our Latest Stock Analysis on Nano-X Imaging
Nano-X Imaging Trading Up 7.8 %
NNOX stock traded up $0.72 during trading on Monday, reaching $9.97. 9,372,810 shares of the stock were exchanged, compared to its average volume of 9,985,895. The firm's 50 day moving average is $6.69 and its 200 day moving average is $6.79. The firm has a market cap of $576.06 million, a P/E ratio of -11.73 and a beta of 1.97. Nano-X Imaging has a twelve month low of $5.26 and a twelve month high of $14.28.
Institutional Trading of Nano-X Imaging
Several institutional investors and hedge funds have recently modified their holdings of NNOX. State Street Corp grew its holdings in Nano-X Imaging by 2.1% during the third quarter. State Street Corp now owns 983,305 shares of the company's stock worth $5,978,000 after buying an additional 20,279 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Nano-X Imaging by 2.2% during the third quarter. Geode Capital Management LLC now owns 677,853 shares of the company's stock worth $4,121,000 after purchasing an additional 14,560 shares during the last quarter. ARK Investment Management LLC grew its position in Nano-X Imaging by 5.2% in the 3rd quarter. ARK Investment Management LLC now owns 252,633 shares of the company's stock worth $1,536,000 after purchasing an additional 12,408 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Nano-X Imaging by 7.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 185,167 shares of the company's stock valued at $1,359,000 after buying an additional 13,085 shares during the last quarter. Finally, Tempus Wealth Planning LLC lifted its position in shares of Nano-X Imaging by 3.6% during the 3rd quarter. Tempus Wealth Planning LLC now owns 121,137 shares of the company's stock worth $737,000 after buying an additional 4,230 shares in the last quarter. 21.49% of the stock is owned by hedge funds and other institutional investors.
About Nano-X Imaging
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Further Reading
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.